Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Revenue

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹14,278 Cr₹12,207 Cr₹10,260 Cr₹8,749 Cr₹7,782 Cr

What is the latest Revenue of MANKIND PHARMA ?

The latest Revenue ratio of MANKIND PHARMA is ₹14,278 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹14,278 Cr
Mar2025₹12,207 Cr
Mar2024₹10,260 Cr
Mar2023₹8,749 Cr
Mar2022₹7,782 Cr

How is Revenue of MANKIND PHARMA Trending?

Years Revenue % Change
Mar2026 ₹14,278 Cr
16.96
Mar2025 ₹12,207 Cr
18.98
Mar2024 ₹10,260 Cr
17.27
Mar2023 ₹8,749 Cr
12.44
Mar2022 ₹7,782 Cr -

Compare Revenue of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,184.5 Cr -1.1% -1.2% 3.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,202.0 Cr 0.5% -2.9% 5% Stock Analytics
DIVIS LABORATORIES ₹264,141.0 Cr 5% 7.2% 49.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,402.0 Cr -0.5% -4.5% 28.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,868.0 Cr 2.7% 8.4% 5.1% Stock Analytics
CIPLA ₹111,650.0 Cr 2.4% 2.4% -12.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.1%

-1.2%

3.1%

SENSEX

2.8%

4.4%

-10.1%


You may also like the below Video Courses